Michael Hoel (), Tore Nilssen (), Jon Vislie and Tor Iversen ()
Additional contact information
Michael Hoel: Department of Economics, Postal: University of Oslo, P.O. Box 1095 Blindern, NO-0317 Oslo, Norway
Tore Nilssen: Department of Economics, Postal: University of Oslo, P.O. Box 1095 Blindern, NO-0317 Oslo, Norway
Jon Vislie: Department of Economics, Postal: University of Oslo, P.O. Box 1089 Blindern, NO-0317 Oslo, Norway
Tor Iversen: Institute of Health Management and Health Economics, Postal: University of Oslo, P.O. Box 1089 Blindern, NO-0317 Oslo, Norway
Abstract: A central theme in the international debate on genetic testing concerns the extent to which insurance companies should be allowed to use genetic information in their design of insurance contracts. This issue is analysed within a model with the following important feature: A person's well-being depends on the perceived probability of becoming ill in the future in a way that varies among individuals.
The authors show that both tested high-risks and untested individuals are equally well off whether or not test results can be used by insurers. Individuals who test for being low-risks, on the other hand, are made worse off by not being able to verify this to insurers. This implies that verifiability dominates non-verifiability in an ex-ante sense.
Keywords: Health insurance; isurance contracts; genetic testing; genetic information
17 pages, June 29, 2009
Full text files
HERO2002_10.pdf
Questions (including download problems) about the papers in this series should be directed to Kristi Brinkmann Lenander ()
Report other problems with accessing this service to Sune Karlsson ().
RePEc:hhs:oslohe:2002_010This page generated on 2024-09-13 22:16:49.